期刊文献+

硫酸氢氯吡格雷与阿托伐他汀钙联合治疗急性冠脉综合征 被引量:1

Discussion of Clopidogrel Combined Atorvastatin in Treatment of Acute Coronary Syndrome
下载PDF
导出
摘要 目的探讨硫酸氢氯吡格雷联合阿托伐他汀钙治疗急性冠脉综合征的临床疗效。方法选择60例急性冠脉综合征患者,随机分为常规治疗组和联合治疗组,观察两组治疗前后患者空腹血清高敏C反应蛋白及血脂的变化。结果联合治疗组治疗后检测hs-CRP与常规治疗组相对比下降幅度有非常显著性差异(P<0.01);联合治疗组治疗后检测血脂水平与常规治疗组相对比下降幅度有显著性差异(P<0.05)。结论硫酸氢氯吡格雷联合阿托伐他汀钙治疗ACS患者,除抑制血小板聚集外,还有独立的抗炎作用,是一种有效的治疗手段。 Objective To evaluate the clinical effect of clopidogrel and atorvastatin in patients of acute coronary syndrome. Methods With methods of random grouping, 60 patients of acut coruonary syndrome were divided into routine treatment group and combined treatment group, change of fasting serum high sensitive C-reative protein and serum lipid were observed in all patients of two groups pre and post treatment. Results After treatment,there were very significant difference(P〈 0.01 ) between the descent range of hs-CRP of routine treatment group and combined treatment group, there were significant difference(P〈 0.05 ) between the descent range of serum lipid of the two groups. Conclusion Clopidogrel combined with atorvastatin can inhibit platelet aggregation and has an independent anti-inflammatory effect.
作者 赵强
出处 《中国现代医生》 2009年第8期96-97,共2页 China Modern Doctor
关键词 硫酸氢氯吡格雷 阿托伐他汀钙 急性冠脉综合征 Clopidogrel Atorvastatin Acut cornonary syndrome
  • 相关文献

参考文献8

二级参考文献84

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33029
  • 2[1]Schwartz GG, Olsson AG, Ezekowitz M, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial [J]. JAMA, 2001, 285(13):1711-1718.
  • 3[2]Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis [J]. Circulation, 2002, 105(9):1135-1143.
  • 4[3]Kinlay S, Selwyn AP. Effects of statins on inflammation in patients with acute and chronic coronary syndromes[J]. Am J Cardiol, 2003,91(4A):9B-13B.
  • 5[4]Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inlammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization [J]. Circulation, 2001, 103(7):926-933.
  • 6[5]Kinlay S, Timms T, Clark M, et al. Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia[J]. Am J Cardiol, 2002, 89(10):1205-1207.
  • 7[6]Plenge JK, Hernandez TL, Weil KM, et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction[J]. Circulation, 2002, 106(12): 1447-1452.
  • 8[7]Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE):a randomized trial and cohort study[J]. JAMA, 2001,286(1):64-70.
  • 9[8]Ardissino D, Merlini PA, Ariens R, et al. Tissue-factor antigen and activity in human coronary atherosclerotic plaques[J]. Lancet, 1997, 349(9054):769-771.
  • 10[9]Baetta R, Camera M, Comparato C, et al. Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering[J]. Arterioscler Thromb Vasc Biol, 2002, 22(4):692-698.

共引文献127

同被引文献14

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部